Emergency Use Authorization (English Wikipedia)
Analysis of information sources in references of the Wikipedia article "Emergency Use Authorization" in English language version.
refsWebsite
Global rank
English rank
7th place
7th place
11th place
8th place
54th place
48th place
1st place
1st place
doi.org
- Webb, Jamie; Shah, Lesha D.; Lynch, Holly Fernandez (September 1, 2020). "Ethically Allocating COVID-19 Drugs Via Pre-approval Access and Emergency Use Authorization". The American Journal of Bioethics. 20 (9): 4–17. doi:10.1080/15265161.2020.1795529. S2CID 221324833.
- Rizk, John G.; Forthal, Donald N.; Kalantar-Zadeh, Kamyar; Mehra, Mandeep R.; Lavie, Carl J.; Rizk, Youssef; Pfeiffer, JoAnn P.; Lewin, John C. (November 2020). "Expanded Access Programs, compassionate drug Use, and Emergency Use Authorizations during the COVID-19 pandemic". Drug Discovery Today. 26 (2): 593–603. doi:10.1016/j.drudis.2020.11.025. PMC 7694556. PMID 33253920.
fda.gov
- "Emergency Use Authorization of Medical Products and Related Authorities". US Food and Drug Administration. January 2017. Retrieved May 14, 2020.
- "FDA Authorizes Emergency Use of Influenza Medicines, Diagnostic Test in Response to Swine Flu Outbreak in Humans. FDA News, April 27, 2009". Food and Drug Administration.
- "Coronavirus Disease 2019 (COVID-19) Emergency Use Authorizations for Medical Devices". fda.gov. FDA U.S. Food & Drug Administration. Retrieved October 19, 2020.
- "Emergency Use Authorization (EUA) of Remdesivir for Coronavirus Disease 2019 (COVID-19)". U.S. Food and Drug Administration. May 1, 2020.
- "Coronavirus (COVID-19) Update: FDA Revokes Emergency Use Authorization for Monoclonal Antibody Bamlanivimab". U.S. Food and Drug Administration (FDA) (Press release). April 16, 2021. Retrieved April 16, 2021.
This article incorporates text from this source, which is in the public domain. - "2020 Meeting Materials, Vaccines and Related Biological Products Advisory Committee". FDA. December 3, 2020.
forbes.com
- Bruce Japsen. "U.S. Approves Abbott Labs Coronavirus Test For Hospital Use". Forbes. Retrieved April 7, 2020.
nih.gov
ncbi.nlm.nih.gov
- Rizk, John G.; Forthal, Donald N.; Kalantar-Zadeh, Kamyar; Mehra, Mandeep R.; Lavie, Carl J.; Rizk, Youssef; Pfeiffer, JoAnn P.; Lewin, John C. (November 2020). "Expanded Access Programs, compassionate drug Use, and Emergency Use Authorizations during the COVID-19 pandemic". Drug Discovery Today. 26 (2): 593–603. doi:10.1016/j.drudis.2020.11.025. PMC 7694556. PMID 33253920.
pubmed.ncbi.nlm.nih.gov
- Rizk, John G.; Forthal, Donald N.; Kalantar-Zadeh, Kamyar; Mehra, Mandeep R.; Lavie, Carl J.; Rizk, Youssef; Pfeiffer, JoAnn P.; Lewin, John C. (November 2020). "Expanded Access Programs, compassionate drug Use, and Emergency Use Authorizations during the COVID-19 pandemic". Drug Discovery Today. 26 (2): 593–603. doi:10.1016/j.drudis.2020.11.025. PMC 7694556. PMID 33253920.
nytimes.com
- Holland S, Mason J, Maler S (May 1, 2020). "FDA Authorizes Remdesivir Drug for COVID-19". The New York Times.
- Benjamin Mueller (December 2, 2020). "U.K. Approves Pfizer coronavirus vaccine, a first in the West". The New York Times. Retrieved December 2, 2020.
semanticscholar.org
api.semanticscholar.org
- Webb, Jamie; Shah, Lesha D.; Lynch, Holly Fernandez (September 1, 2020). "Ethically Allocating COVID-19 Drugs Via Pre-approval Access and Emergency Use Authorization". The American Journal of Bioethics. 20 (9): 4–17. doi:10.1080/15265161.2020.1795529. S2CID 221324833.
web.archive.org
- Vaccines and Related Biological Products Advisory Committee - 12/10/2020 meeting. Archived from the original on December 10, 2020. Retrieved December 10, 2020.
{{cite AV media}}: CS1 maint: bot: original URL status unknown (link)